Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Phathom Pharmaceuticals, Inc. (PHAT)
|
Add to portfolio |
|
|
|
| Price: |
$20.06
| | Metrics |
| OS: |
56.8
|
M
| |
-1051
|
% ROE
|
| Market cap: |
$1.14
|
B
| |
|
|
|
Net cash:
|
$249
|
M
| |
$4.38
|
per share
|
|
EV:
|
$891
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($201)
|
M
| |
|
|
|
EBIT
|
($202)
|
M
| |
|
|
| EPS |
($4.46)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 172.4 | 135.1 | 125.7 | | |
| Research and development | | | | 20.4 | 0.0 |
| General and administrative | | | | 6.9 | 1.2 |
| EBIT | -196.4 | -143.1 | -128.8 | -27.3 | -1.2 |
| Pre-tax income | -197.7 | -143.9 | -129.1 | -255.1 | -1.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -197.7 | -143.9 | -129.1 | -255.1 | -1.3 |
| |
| Diluted EPS | ($5.05) | ($3.89) | ($3.88) | ($22.45) | ($0.21) |
| Shares outstanding (diluted) | 39.1 | 37.0 | 33.2 | 11.4 | 6.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|